Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab-Reference-Cited by-同舟云学术

Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

Published:2019-12-05 Issue:7 Volume:61 Page:990-998
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Rossi Giovanni,Bauckneht Matteo,Genova Carlo,Rijavec Erika,Biello Federica,Mennella Simone,Dal Bello Maria Giovanna,Cittadini Giuseppe,Bruzzi Paolo,Piva Roberta,Ceriani Valentina,Sambuceti Gianmario,Lopci Egesta,Morbelli Silvia,Grossi Francesco

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference32 articles.

1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2. Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: systematic review;Hotta;PLoS One.,2015

3. Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy;Akamatsu;BMC Cancer.,2014

4. Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

5. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis;Beaver;Lancet Oncol.,2018

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067);European Journal of Nuclear Medicine and Molecular Imaging;2024-07-02

2. [18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-19

3. Schrodinger's cat and Deauville 5 point scoring;Clinical Imaging;2023-09

4. Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop;The Lancet Oncology;2023-03

5. ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors;Cancers;2023-01-31